NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) today announced that on Monday, November 17, 2008, the German Federal Cartel Office (FCO) granted clearance for the acquisition of all of ImClone’s common stock at a price of $70.00 per share by Alaska Acquisition Corporation, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY), pursuant to the previously announced tender offer and Agreement and Plan of Merger. The tender offer is scheduled to expire at 12:00 midnight, New York City time, on November 20, 2008.
